These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 579054)

  • 1. Increased plasma binding and decreased blood cell binding of quinidine in blood from anuric rats.
    Fremstad D
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):148-60. PubMed ID: 579054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of serum protein binding on the pharmacokinetics of quinidine in normal and anuric rats.
    Fremstad D; Jacobsen S; Lunde KM
    Acta Pharmacol Toxicol (Copenh); 1977 Aug; 41(2):161-76. PubMed ID: 579055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.
    Nilsen OG; Fremstad D; Jacobsen S
    Eur J Pharmacol; 1975 Aug; 33(1):131-9. PubMed ID: 1175679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of quinidine in serum and heart from normal and anuric rats, and the significance for distribution.
    Fremstad D; Jacobsen S
    Biochem Pharmacol; 1979 Sep; 28(17):2611-6. PubMed ID: 42403
    [No Abstract]   [Full Text] [Related]  

  • 5. Quinidine and dihydroquinidine interactions in human plasma.
    Ueda CT; Makoid MC
    J Pharm Sci; 1979 Apr; 68(4):448-50. PubMed ID: 438966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.
    Doering W; Fichtl B; Herrmann M; Besenfelder E
    Eur J Clin Pharmacol; 1982; 21(4):281-5. PubMed ID: 7056272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between in-vivo and in-vitro tissue-to-plasma unbound concentration ratios (Kp,f) of quinidine in rats.
    Harashima H; Sugiyama Y; Sawada Y; Iga T; Hanano M
    J Pharm Pharmacol; 1984 May; 36(5):340-2. PubMed ID: 6145776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of quinidine related to plasma protein binding in man.
    Fremstad D; Nilsen OG; Storstein L; Amlie J; Jacobsen S
    Eur J Clin Pharmacol; 1979 Apr; 15(3):187-92. PubMed ID: 456401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the binding of quinine and quinidine to plasma proteins.
    Mihaly GW; Ching MS; Klejn MB; Paull J; Smallwood RA
    Br J Clin Pharmacol; 1987 Dec; 24(6):769-74. PubMed ID: 3440096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of quinidine in the rabbit.
    Guentert TW; Huang JD; Oie S
    J Pharm Sci; 1982 Jul; 71(7):812-5. PubMed ID: 7120069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure.
    Izuwa Y; Kusaba J; Horiuchi M; Aiba T; Kawasaki H; Kurosaki Y
    Drug Metab Pharmacokinet; 2009; 24(5):451-7. PubMed ID: 19881257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of increased plasma protein binding on the disposition of quinidine in turpentine-treated rats.
    Sugihara N; Furuno K; Kita N; Murakami T; Yata N
    Biol Pharm Bull; 1993 Jan; 16(1):63-7. PubMed ID: 8369755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting quinidine protein binding in humans.
    Edwards DJ; Axelson JE; Slaughter RL; Elvin AT; Lalka D
    J Pharm Sci; 1984 Sep; 73(9):1264-7. PubMed ID: 6491948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cimetidine on quinidine distribution and tissue pH in rats.
    Shibasaki S; Kawamata Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Jun; 12(6):324-31. PubMed ID: 2778625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
    Yu VC; de Lamirande E; Horning MG; Pang KS
    Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
    Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
    Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cimetidine on quinidine distribution in rats.
    Shibasaki S; Komoriya K; Gon S; Matsuura Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1987 Dec; 10(12):719-26. PubMed ID: 3451957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.